Effect the Glycemic Control on Cardiac Function
Launched by ASSIUT UNIVERSITY · Jan 6, 2025
Trial Information
Current as of July 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how managing blood sugar levels, known as glycemic control, can affect heart function in people with type 2 diabetes who also have heart diseases. The goal is to understand if better control of blood sugar can lead to improved heart health.
To participate in this trial, you need to have type 2 diabetes and a heart condition. Unfortunately, people with type 1 diabetes, those who experienced diabetes during pregnancy, patients with severe kidney disease requiring dialysis, and individuals with immune system disorders are not eligible. If you qualify and decide to join, you will be involved in assessments that may help improve our understanding of the connection between blood sugar management and heart health in diabetes. The trial is not currently recruiting participants, so it may take some time before it begins.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • type 2 diabetic patients with heart diseases
- Exclusion Criteria:
- • patients with type 1 diabetes mellitus
- • gestational DM
- • CKD patients requiring haemodialysis
- • Immune system disorder
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Mohamed Hossam Hassan, Professor
Study Chair
Assiut University
Hanaa Mohamed Riad, Doctor (lecture)
Study Director
Assiut University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported